Despite the expression of ACSL4 and the inhibition of GPX4, tumor cells continue to exhibit resistance to ferroptosis, indicating the presence of alternative resistance mechanisms (Bersuker et al., 2019; Doll et al., 2019). The gene discussed is GPX4; the disease is neoplasm.